In a study of IDH1-mutant (IDH1-mt) gliomas, one study found decreased triglycerides and sphingolipids and elevated pyruvate entering the TCA cycle in IDH1-mt gliomas compared to IDH-wt (Zhou et al., 2019). This evidence concerns the gene IDH2 and central nervous system cancer.